logo-loader
RNS
EMV Capital

EMV Capital PLC - Portfolio Update

RNS Number : 6833S
EMV Capital PLC
12 February 2026
 

For announcement on Reach: 12 February 2026

 

EMV Capital plc

 

("EMVC" or the "Company")

 

Portfolio Update

 

As part of its ongoing investor engagement programme, EMV Capital plc (AIM: EMVC), the deep tech and life sciences VC investment group, is pleased to announce that it will host a virtual Meet the Portfolio event on 26 February 2026 at 02.00 p.m. The session will provide investors with greater insight into two of its portfolio companies, Vortex and DName-iT.

 

Virtual Meet the Portfolio - Vortex and DName-iT

 

The online event will take place via the Investor Meet Company platform and will be hosted by Dr Ilian Iliev, CEO of EMV Capital plc, who will be joined by:

·     The Managing Director of Vortex, a leader in liquid biopsy technologies for precision oncology; and

·     The CEO of DName-iT, a MedTech company applying its patented DNA barcoding method to develop a platform for labelling patients' specimens that are analysed with Next Generation Sequencing.

This presentation is open to all interested parties. Anyone can sign up for free and join the live presentation via:

https://www.investormeetcompany.com/emv-capital-plc/register-investor

Those who already follow the Company on the Investor Meet Company platform will automatically be invited.

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 25 February 2026 at 09:00 a.m., or at any time during the live presentation.

In accordance with UK Market Abuse Regulation (UK MAR), no inside information will be disclosed during the event.

 

-Ends- 

 

For more information, please contact:

 

 

EMV Capital plc

via Rosewood

 

Ilian Iliev, CEO

 

 

 

Panmure Liberum Limited (NOMAD and Broker)

+44 (0)20 7886 2500

 

Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)

 

 

Rupert Dearden (Corporate Broking)

 

 

 

Rosewood (Financial PR)

+44 (0)20 7653 8702

John West / Llewellyn Angus / Lily Pearce


 

 

About EMV Capital plc (EMVC)

 

EMV Capital plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early-stage IP-rich companies.

EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:

·     capital-efficient investments through Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds;

·     syndicated investments leveraging its network of third-party investors.

EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.

Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

www.emvcapital.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUAVORNOUUAUR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

EMV Capital reports strong 2024 Growth, eyes expansion with new fund launch...

EMV Capital CEO Dr. Ilian Iliev joined Steve Darling from Proactive to provide a comprehensive update on the firm’s strong performance in 2024 and its strategic roadmap as it heads into 2025. Despite persistent macroeconomic headwinds, EMV Capital demonstrated notable resilience and growth,...

on 4/6/25

3 min read